Rick E. Winningham, Director at Jazz Pharmaceuticals plc (JAZZ), sold 2,741 shares at $241.57 ($662K) on 2026-05-22, disclosed to the SEC on 2026-05-27.
Open-market sale of $662k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |